Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03706274
Recruitment Status : Not yet recruiting
First Posted : October 15, 2018
Last Update Posted : July 30, 2019
Sponsor:
Information provided by (Responsible Party):
CytomX Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : December 2020
  Estimated Study Completion Date : December 2022